GSK, Pfizer Agree to End Patent Lawsuit Over Rival RSV Vaccines
GSK Plc and Pfizer Inc. settled a patent-infringement lawsuit over competing vaccines for RSV, ending the dispute in Delaware ...
Fierce Pharma18h
GSK, Pfizer resolve RSV patent feud amid vaccine market uncertainty
As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...
The Value of Moderna's mRNA Technology Is Obscured by Fears of a Hostile US Regulatory Environment
Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...
GSK Resolves Patent Lawsuit Against Pfizer Over RSV Vaccines
(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's ...
Health Care Roundup: Market Talk
Find insight on Sartorius, China’s healthcare industry and more in the latest Market Talks covering health care.
Pharmaceutical Technology on MSN1d
Pharma industry dodges tariff blow but still braces for disruption
According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.
GSK: Under Threat From 'Double Whammy' Of Vaccine Skepticism And Pharma Tariffs
Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...
Is GSK plc (GSK) the Most Undervalued Healthcare Stock to Buy According to Analysts?
We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...
Energy Digital4d
Renewables: AstraZeneca & GSK to Cut Healthcare Emissions
AstraZeneca, GSK & partners will source 225GWh of renewable power in China, cutting emissions by 250,000 tonnes – equal to ...